by Lisa Willemse | Jul 14, 2014
Written with contributions from Geoff Lomax, CIRM’s Senior Officer for Medical and Ethical Standards and Rosario Isasi, Research Associate at McGill University and Academic Secretary for the International Stem Cell Forum Ethics Working Party. Portions of this post...
by Lisa Willemse | Jul 4, 2014
> It’s July the 4th, a date that most people, or at least Americans, equate with celebrations and fireworks. Less known in the broader world is July 1st, which happens to be Canada Day in my neck of the woods. It also features celebration and fireworks. As...
by David Kent | Jun 19, 2014
> Just four hours after landing in Vancouver for the 2014 meeting of the International Society for Stem Cell Research, I was delighted to attend the late afternoon plenary session on Cell Heterogeneity. Both John Dick and Connie Eaves – juggernauts of the Canadian...
by Sara M. Nolte | Jun 9, 2014
> I recently wrote about the dilemma many cancer stem cell (CSC) researchers face when trying to model their disease of interest in the lab. So assuming a researcher has successfully chosen their model – what happens next? Allow me to introduce to you some of the...
by Nick Dragojlovic | May 26, 2014
> In a recent post on Signals, David Kent made the case for government-funded clinical trials of autologous stem cell therapies, since the lack of proven commercialization models in this area make it difficult to attract private investment. Another way of financing...
Comments